Compare · BIS vs DWEQ

BIS vs DWEQ

Side-by-side comparison of ProShares UltraShort Nasdaq Biotechnology (BIS) and AdvisorShares Dorsey Wright Alpha Equal Weight ETF (DWEQ): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BIS and DWEQ operate in n/a (n/a), so they compete in similar markets.
MetricBISDWEQ
Company
ProShares UltraShort Nasdaq Biotechnology
AdvisorShares Dorsey Wright Alpha Equal Weight ETF
Price
-
-
Market cap
-
-
1M return
-
-
1Y return
-
-
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NASDAQ
IPO
n/a
n/a
News (4w)
0
0
Recent ratings
0
0
BIS

ProShares UltraShort Nasdaq Biotechnology

The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

DWEQ

AdvisorShares Dorsey Wright Alpha Equal Weight ETF

The investment seeks to provide long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in a concentrated portfolio of U.S. equity securities selected from a universe of the largest 1,000 U.S. equity securities based on market capitalization. It's investment focus follows a core philosophy of relative strength. The fund also may invest in repurchase agreements.

Latest BIS

Latest DWEQ

No recent items for AdvisorShares Dorsey Wright Alpha Equal Weight ETF.